Yale School of Medicine: Promising Treatment on the Horizon for Cancer-Related Fatigue
October 04, 2023
October 04, 2023
NEW HAVEN, Connecticut, Oct. 4 (TNSres) -- The Yale University School of Medicine issued the following news:
Researchers say DCA could be a practice-changing approach in the future, when used as an adjuvant therapy to treat cancer-related fatigue.
Cancer-related fatigue (CRF) is a debilitating yet all-too-common condition, which can severely affect quality of life for patients undergoing treatment. For those struggling with CRF, there have been no effective pharmaceutic . . .
Researchers say DCA could be a practice-changing approach in the future, when used as an adjuvant therapy to treat cancer-related fatigue.
Cancer-related fatigue (CRF) is a debilitating yet all-too-common condition, which can severely affect quality of life for patients undergoing treatment. For those struggling with CRF, there have been no effective pharmaceutic . . .